Analysis of Internal and External Factors for AstraZeneca

This report provides an analysis of the business environment of AstraZeneca, a leading pharmaceutical company. It utilizes SWOT and PESTLE analyses to examine both internal and external factors influencing the organization. The SWOT analysis assesses the company's strengths (innovation, R&D, financial performance), weaknesses (public relations, drug failure, leadership), opportunities (emerging markets, aging population) and threats (acquisitions, generics, rising drug development costs). The PESTLE analysis explores political factors (Brexit, government spending), economic factors (drug pricing, R&D returns), social factors (aging population, lifestyle changes, income levels), technological factors (innovation, AI), legal factors (drug approvals, GDPR, tax changes), and environmental factors (climate change). The report highlights the impact of these factors on AstraZeneca, emphasizing its contributions to climate change and its responses to various challenges.

\
Business environment can be defined as the analysis of
the internal and external environment of the business so
that an organization can examine the impact of company
on the business environment (Khajeheian, Friedrichsen
and Mödinger, 2018). Organization chosen here is
AstraZeneca, it is one of the leading international
pharmaceutical company based in UK in 1999. It mainly
deals with the products like medicines and other
medical equipments and requirements. The following
discussion is made on the internal factors that is SWOT
analysis, external factors that is PESTLE analysis and
impact of business on it's external factors in context of
AstraZeneca.
Environment factors: Role of leadership is taken by the
company to fight against the climate change globally
Internal factors
SWOT Analysis: It is defined as the analysis that affects the
internal environment of the business which includes the
company's strengths, weaknesses, opportunities and threats
(Teoli and An, 2019).
Strengths: Ranked first company in terms of innovation.
High usage of research and development among the industry
leaders. Financial performance is strong.
Weaknesses: Image in public relations are bad along with
complicated controversies associated with it. Failure in rate
of drugs resulted in high losses in its operations. Leadership
and effective management is lacking. Opportunities: It has a
growth opportunity in an emerging market that can be
considered as the drivers of future for growth. Threats: It is
facing acquisition by financially wealthier, bigger and
powerful companies in an industry. Generics has led to the
losses and very low revenue generations in an organization.
Drug development cost is increasing day by day.
How the company impact its context External
Environment
Company has a moderate impact on political factors
due to Brexit and support by government
Company has a moderate impact on economical factors
due to less drugs prices and deteriorating returns
Company has growth opportunities in it's social factors
due to increase in ageing, disease and income levels
Company has growth opportunities in it's technological
factors due to innovation and artificial intelligence
Company is facing threats in terms of legal factors due
to GDPR, CTR and decline in drug approval
Company has growth opportunities in it's
environmental factors due to contributing in global
climate change (Perera, 2017).
External factors
PESTLE Analysis: It is defined as the analysis that
affects the external environment of the business
(Hamilton and Webster, 2018).
Political factors: Brexit is the reason of uncertain
political factor. Increase in government spending and
supporting on healthcare programs.
Economical factors: Drugs prices are being lowered by
the economy of the country. Lack in return on investment
by research and development of the company. Social
factors. Growth opportunities for the firm due to ageing
increase of the population. Growth in number of patients
due to urban lifestyle. Rise in levels of income.
Technological factors: Company is investing in the
centre of building for innovation to promote
manufacturing on a quality basis. Innovation in artificial
intelligence and tracking systems to tackle counterfeits.
Legal factors: Company is facing the declining in the
approval of drugs from the regulatory bodies. Changes in
corporate rate of taxes. GDPR is affecting operations of
an organization.
Individual poster
INTRODUCTION Internal and external factors
References:
Books and Journals
Hamilton, L. and Webster, P., 2018. The international
business environment. Oxford University Press.
Khajeheian, D., Friedrichsen, M. and Mödinger, W., 2018.
An introduction to competitiveness in fast changing business
environment. In Competitiveness in emerging markets (pp.
3-11). Springer, Cham.
Perera, R., 2017. The PESTLE analysis. Nerdynaut.